Cladribine
Links shared publicly online about this topic
Oral cladribine... | Facebook
facebook.com — “National multiple sclerosis society wrote: oral cladribine (sponsored by emd... join facebook to connect with national multiple sclerosis society and others you may know.” View full resource at facebook.com
Most Recently Shared on January 21, 2010 at 3:19 pm By:
Oral cladribine (sponsored by EMD Serono) and fingolimod (sponsored by Novartis) have both been shown to have... http://bit.ly/8JCY2h
Merck: Regulatory Update On Cladribine Tablets
pharmaceuticalonline.com — “Merck: Regulatory Update On Cladribine Tablets - Merck KGaA” View full resource at pharmaceuticalonline.com
Most Recently Shared on June 23, 2011 at 8:31 am By:
Merck: Regulatory Update On Cladribine Tablets: Merck KGaA announced recently that following feedback from regul... http://bit.ly/jGhI2l
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
medicalnewstoday.com — “Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tabl” View full resource at medicalnewstoday.com
Most Recently Shared on September 5, 2010 at 11:56 am By:
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia: Merck KGaA announced that the Australian ... http://mnt.to/f/3JkB
Merck Serono: Regulatory Update On Cladribine Tablets
medicalnewstoday.com — “Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that, following feedback from regulatory authorities, the Company has decided to no longer pursue the global approval pr” View full resource at medicalnewstoday.com
Most Recently Shared on June 22, 2011 at 9:05 am By:
Merck Serono: Regulatory Update On Cladribine Tablets http://mnt.to/3XvL #multiplesclerosis
FDA Extends Review of Cladribine for MS - Pathophilia
bmartinmd.com — “FDA Extends Review of Cladribine for MS - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on November 29, 2010 at 4:30 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
FDA Extends Review of Cladribine for MS: Merck Serono's not out the race to market an oral pill for multiple scl... http://bit.ly/igbV67
FDA Rejects Oral Cladribine for MS - Pathophilia
bmartinmd.com — “FDA Rejects Oral Cladribine for MS - Pathophilia” View full resource at bmartinmd.com
Most Recently Shared on March 2, 2011 at 6:48 pm By:
Barbara J. Martin Doctor, Neurologist, and Physician
FDA Rejects Oral Cladribine for MS: Delivering a minor shock, the FDA issued a complete response letter to Merck... http://bit.ly/ePfRhV
Neurology Medical News about Multiple Sclerosis Cladribine
mdlinx.com — “A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis” View full resource at mdlinx.com
Most Recently Shared on February 5, 2010 at 1:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro:A Placebo-Controlled Trial of Oral #Cladribine for Relapsing Multiple Sclerosishttp://bit.ly/aUCGAQ
Cladribine Tablets For Relapsing Multiple Sclerosis, FDA Extends Priority Review
medicalnewstoday.com — “The Food and Drug Administration (FDA) has extended the review period for Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis by another three months, to give time for a” View full resource at medicalnewstoday.com
Most Recently Shared on November 26, 2010 at 6:09 pm By:
Cladribine Tablets For Relapsing Multiple Sclerosis, FDA Extends Priority Review The Food and Drug Administration (FDA).. http://dld.bz/8jnB
Merck KGaA pulls plug on cladribine on FDA feedback | Reuters
reuters.com — “FRANKFURT (Reuters) - Merck KGaA said U.S. drug regulators' concerns about the risks of its cladribine pill will put an end to any development or marketing plans for the multiple sclerosis (MS) treatment.Merck” View full resource at reuters.com
Most Recently Shared on June 22, 2011 at 10:32 am By:
Merck KGaA pulls plug on cladribine on FDA feedback http://reut.rs/kMYDCT
Merck KGaA pulls plug on cladribine on FDA feedback | Reuters
reuters.com — “FRANKFURT (Reuters) - Merck KGaA said U.S. drug regulators' concerns about the risks of its cladribine pill will put an end to any development or marketing plans for the multiple sclerosis (MS) treatment.Merck” View full resource at reuters.com
Most Recently Shared on June 22, 2011 at 1:22 pm By:
Lisa Richwine Health Communicator
Merck KGaA pulls plug on cladribine on FDA feedback http://tinyurl.com/5sb5xgw
Merck KGaA pulls plug on cladribine on FDA feedback | Reuters
reuters.com — “FRANKFURT (Reuters) - Merck KGaA said U.S. drug regulators' concerns about the risks of its cladribine pill will put an end to any development or marketing plans for the multiple sclerosis (MS) treatment.Merck” View full resource at reuters.com
Most Recently Shared on June 22, 2011 at 10:21 am By:
Merck KGaA pulls plug on cladribine on FDA feedback: FRANKFURT (Reuters) - Merck KGaA said U.S. drug regulators'... http://bit.ly/ksxRvg
Merck KGaA pulls plug on cladribine on FDA feedback | Reuters
reuters.com — “FRANKFURT (Reuters) - Merck KGaA said U.S. drug regulators' concerns about the risks of its cladribine pill will put an end to any development or marketing plans for the multiple sclerosis (MS) treatment.Merck” View full resource at reuters.com
Most Recently Shared on June 22, 2011 at 10:09 am By:
Brad Lipson, DO Doctor, Family Medicine Doctor, Physician, and Active Health Library
Merck KGaA pulls plug on cladribine on FDA feedback: FRANKFURT (Reuters) - Merck KGaA said U.S. drug regul... http://tinyurl.com/4yspkkv
Merck Seeks European License For Cladribine for relapsing remitting MS
medicalnewstoday.com — “Merck Serono announced that it is seeking a European license for cladribine, its oral therapy that is in late-stage clinical trials for relapsing remitting MS. The announcement comes aft” View full resource at medicalnewstoday.com
Most Recently Shared on July 27, 2009 at 11:32 am By:
MedNewsToday: Merck Seeks European License For Cladribine for relapsing remitting MS: Merck Serono .. http://bit.ly/NUQkf
Cladribine Development Discontinued by Merck KGaA | ThirdAge
thirdage.com — “Cases of cancer emerged during cladribine clinical trials, prompting Merck to discontinue marketing and development of the drug” View full resource at thirdage.com
Most Recently Shared on June 22, 2011 at 2:07 pm By:
Cladribine Development Discontinued by Merck KGaA http://bit.ly/mh38Ce
Extension of FDA Review for Cladribine Tablets for Treatment of Relapsing Forms of Multiple Sclerosis
disabled-world.com — “EMD Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis” View full resource at disabled-world.com
Most Recently Shared on November 26, 2010 at 6:03 pm By:
Disabled World Health Advocate and Health News
Extension of FDA Review for Cladribine Tablets for Treatment of Relapsing Forms of Multiple Sclerosis http://ff.im/-uoaoJ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
National MS Society
Multiple sclerosis stops people from moving. We exist to make sure it doesn't.
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
